Evolent Health, Inc.: diluted weighted-average shares
Diluted weighted-average shares for Evolent Health, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Evolent Health, Inc. financial histories
What this measure means
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 114,208,000 | shares | 2026-02-25 | 10-K · 0001628908-26-000015 |
| 2024-01-01 | 2024-12-31 | 114,682,000 | shares | 2026-02-25 | 10-K · 0001628908-26-000015 |
| 2023-01-01 | 2023-12-31 | 111,251,000 | shares | 2026-02-25 | 10-K · 0001628908-26-000015 |
| 2022-01-01 | 2022-12-31 | 93,699,000 | shares | 2025-02-21 | 10-K · 0001628908-25-000020 |
| 2021-01-01 | 2021-12-31 | 86,067,000 | shares | 2024-02-23 | 10-K · 0001628908-24-000017 |
| 2020-01-01 | 2020-12-31 | 84,928,000 | shares | 2023-02-24 | 10-K · 0001628908-23-000029 |
| 2019-01-01 | 2019-12-31 | 82,364,000 | shares | 2022-02-24 | 10-K · 0001628908-22-000027 |
| 2017-01-01 | 2017-12-31 | 64,351,000 | shares | 2018-03-01 | 10-K · 0001628908-18-000015 |
| 2016-01-01 | 2016-12-31 | 45,031,000 | shares | 2018-03-01 | 10-K · 0001628908-18-000015 |
| 2015-01-01 | 2015-12-31 | 46,136,000 | shares | 2018-03-01 | 10-K · 0001628908-18-000015 |
| 2014-01-01 | 2014-12-31 | 2,314,000 | shares | 2017-03-03 | 10-K · 0001628908-17-000006 |
| 2013-01-01 | 2013-12-31 | 2,988,000 | shares | 2016-02-29 | 10-K · 0001628908-16-000030 |
Related financial histories
- Evolent Health, Inc.: total assets
- Evolent Health, Inc.: total liabilities
- Evolent Health, Inc.: stockholders equity
- Evolent Health, Inc.: cash and cash equivalents
- Evolent Health, Inc.: net income or loss
- Evolent Health, Inc.: operating cash flow
- Evolent Health, Inc.: capital expenditure payments
- Evolent Health, Inc.: revenue
- Evolent Health, Inc.: contract revenue excluding tax
- Evolent Health, Inc.: financing cash flow
- Evolent Health, Inc.: investing cash flow
- Evolent Health, Inc.: retained earnings or deficit
- Evolent Health, Inc.: basic weighted-average shares
- Evolent Health, Inc.: basic earnings per share
- Evolent Health, Inc.: diluted earnings per share
- Evolent Health, Inc.: income tax expense or benefit
- Evolent Health, Inc.: net property, plant and equipment
- Evolent Health, Inc.: share-based compensation expense
- Evolent Health, Inc.: operating income or loss
- Evolent Health, Inc.: current assets
- Evolent Health, Inc.: interest expense
- Evolent Health, Inc.: current liabilities
- Evolent Health, Inc.: current accounts payable
- Evolent Health, Inc.: goodwill carrying amount
- Evolent Health, Inc.: net finite-lived intangible assets
- Evolent Health, Inc.: net current accounts receivable
- Evolent Health, Inc.: common-stock repurchase payments
- Evolent Health, Inc.: operating expenses
- Evolent Health, Inc.: cost of revenue
- Evolent Health, Inc.: selling, general and administrative expense
- Evolent Health, Inc.: research and development expense
Inspect the source
- Entity
- Evolent Health, Inc. / CIK 0001628908
- Captured
- 2026-09-21T17:22:13.053Z
- SEC response SHA-256
7f06e944a853c803c565930baee468aa8736c938ad7257c4dd4079bff760bac6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001628908.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))